PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.\', \'Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.\', \'Specialised Centre for Emergency and Disaster Pharmacy, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.\', \'Pharmacy of the Eastern Vaud Hospitals, Rennaz, Switzerland.\', \'Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.\', \'Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.\', \'Exvastat Ltd., Cambridge, UK.\', \'Department of Clinical Chemistry, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/psp4.12718
?:hasPublicationType
?:journal
  • CPT: pharmacometrics & systems pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34608769
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34608769>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34608769>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all